Previous Article | Next Article 
Infection and Immunity, September 2000, p. 5284-5292, Vol. 68, No. 9
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Cytokine Responses to Treponema pectinovorum and
Treponema denticola in Human Gingival Fibroblasts
Connie S.
Nixon,1
Michelle J.
Steffen,2 and
Jeffrey L.
Ebersole1,2,*
Departments of
Microbiology1 and
Periodontics,2 University of Texas
Health Science Center at San Antonio, San Antonio, Texas 78284
Received 15 November 1999/Returned for modification 15 December
1999/Accepted 15 June 2000
 |
ABSTRACT |
Human gingival fibroblasts were challenged with Treponema
pectinovorum and Treponema denticola to test three
specific hypotheses: (i) these treponemes induce different cytokine
profiles from the fibroblasts, (ii) differences in cytokine profiles
are observed after challenge with live versus killed treponemes, and
(iii) differences in cytokine profiles are noted from different
gingival fibroblast cell lines when challenged with these treponemes.
Three normal gingival fibroblast cell cultures were challenged with T. pectinovorum and T. denticola strains, and
the supernatants were analyzed for cytokine production (i.e.,
interleukin-1
[IL-1
], IL-1
, IL-6, IL-8, IL-10, gamma
interferon, macrophage chemotactic protein 1 [MCP-1],
platelet-derived growth factor, tumor necrosis factor alpha, and
granulocyte-macrophage colony-stimulating factor). Unstimulated
fibroblast cell lines produced IL-6, IL-8, and MCP-1. T. pectinovorum routinely elicited the greatest production of these
cytokines from the fibroblast cell lines, increasing 10- to 50-fold
over basal production. While T. denticola also induced IL-6
and IL-8 production, these levels were generally lower than those
elicited by challenge with T. pectinovorum. MCP-1 levels were significantly lower after T. denticola challenge, and
the kinetics suggested that this microorganism actually inhibited basal
production by the fibroblasts. No basal or stimulated production of the
other cytokines was observed. Significant differences were noted in the
responsiveness of the various cell lines with respect to the two
species of treponemes and the individual cytokines produced. Finally,
dead T. pectinovorum generally induced a twofold-greater level of IL-6 and IL-8 than the live bacteria. These results supported the idea that different species of oral treponemes can elicit proinflammatory cytokine production by gingival cells and that this
stimulation did not require live microorganisms. Importantly, a unique
difference was noted in the ability of T. pectinovorum to
induce a robust MCP-1 production, while T. denticola
appeared to inhibit this activity of the fibroblasts. While the general cytokine profiles of the fibroblast cell cultures were similar, significant differences were noted in the quantity of individual cytokines produced, which could relate to individual patient variation in local inflammatory responses in the periodontium.
 |
INTRODUCTION |
Periodontal disease is clinically
identified as an inflammation of the soft tissues and loss of
connective tissue attachment and bone, surrounding the teeth, resulting
from accumulation of bacteria in a biofilm within the subgingival
sulcus (9). Depending on the quality and quantity of
inflammation, including the characteristics of the immune cells and
soluble mediators of cell communication and inflammation, associated
irreversible tissue destruction represents the transition from
gingivitis to periodontitis.
Numerous bacterial genera and species have been identified in the oral
cavity (26). Presumably, they each play different, and
potentially unique, roles in the ecosystem that develops within this
niche in the oral cavity. Numerous investigations have noted a
succession of bacterial species, which develop in an orderly fashion in
the supragingival and subgingival areas of the gums and teeth (26,
42). If the biofilm remains undisturbed, the bacterial mass
accumulates and the bacteria multiply and metabolize in this ecology.
This biofilm structure or its individual components contribute to
disruption of the epithelial tissue of the gingiva. As this occurs,
serum exudes from the tissues into the sulcus and becomes available to
the bacteria as nutrients, thus changing the local environment. As the
environmental conditions of these ecosystems change, different species
of bacteria are selected and emerge in the ecology. Among the proposed
virulent species, which appear later in plaque maturation, are the
spirochetes (21). Thus, spirochetes in the subgingival
plaque are frequently correlated with periodontal disease and tissue
destruction (40). The spirochetes are generally isolated
during inflammation and disease, in contrast to healthy sites where few
or no treponemes are isolated (41). Treponema
pectinovorum and Treponema denticola are both
gram-negative anaerobic spirochetes that are associated with adult and
juvenile periodontitis (21, 26, 40, 42). Generally, these
species are isolated from the subgingival plaque along with a
substantial variety of other genera and species that comprise the
complex biofilm and create a milieu of nutrient and waste product interdependencies.
The periodontium is a complex tissue structure comprised of resident
cells, including epithelial cells, fibroblasts, and bone, as well as
inflammatory cells of various types, which emigrate from the
microvasculature of the gingiva in response to plaque accumulation
(38). All of these cells can respond to challenges by
bacteria and their products (30, 44). In the presence of initial stimulation, resident cells in the gingival tissue (i.e., epithelium and gingival fibroblasts) release various cell communication signals in the form of chemical cytokines. This in vivo process has
been confirmed by the detection of various pro- and anti-inflammatory cytokines in the gingival crevicular fluid (44). While there is an ever-increasing list of cytokines that provide for normal cell
communication, some of these have been more closely linked with
periodontitis (11, 16, 25, 30-33, 35, 46, 52), including
interleukin-1
(IL-1
), IL-6, IL-8, and tumor necrosis factor alpha
(TNF-
). Additionally, various other cytokines have been implicated
in chronic inflammatory diseases, including: granulocyte-macrophage colony-stimulating factor (GM-CSF [13]), gamma
interferon (IFN-
[8]), macrophage chemotactic
protein 1 (MCP-1 [3, 53]), and IL-10 (5).
However, the primary cellular source for individual cytokines, as well
as the potency and specificity of individual bacterial stimuli in
periodontitis, remains to be determined.
Numerous host cells, including gingival fibroblasts, have the ability
to respond to receptor stimulation by the production of a variety of
substances that include paracrine and autocrine cytokines and growth
factors. We have noted that both T. pectinovorum and
T. denticola bind to gingival fibroblasts at a similar
density, but they do not appear to compete for binding sites
(49). One interpretation of this finding is that these two
related bacteria bind to different receptors on the cells. Since
different receptors often signal specific cytokine responses it could
be predicted that these two treponemes could elicit different types of
cytokine production. Definition of the profile of cytokines resulting
from bacterial stimulation of gingival fibroblasts should result in a
clearer understanding of host-bacterium interactions in the periodontium, which can lead to a breakdown of the local tissue homeostasis. In these experiments we evaluated the pattern of cytokines
produced by human gingival fibroblasts (HGFs) when challenged with
T. denticola and T. pectinovorum. Three specific
hypotheses were tested: (i) T. denticola and T. pectinovorum induce different cytokine profiles produced by
gingival fibroblasts, (ii) differences in cytokine profiles result when
gingival fibroblasts are challenged with live versus killed treponemes,
and (iii) variations in cytokine profiles are observed with different
gingival fibroblast cell lines when challenged with these treponemes.
We suggest that these differences reflect interactions with different
surface receptors on gingival fibroblasts and could impact upon the
characteristics of the local inflammatory milieu at the site of
colonization by each of these microorganisms.
 |
MATERIALS AND METHODS |
Bacterial strains and growth conditions.
T.
pectinovorum strains ATCC 33768 and S1 (20) and
T. denticola strains ATCC 35404, 33520, and GM-1
(50) were grown anaerobically in a Coy anaerobic chamber.
The T. pectinovorum strains were grown for 36 h in NOS
media supplemented with 3 ml of thymine, 3 ml of cysteine, 5 ml of
fatty acids, 20 ml of sodium bicarbonate, and 3 g of pectin per
liter (6, 20). T. denticola strains were grown
for 48 h in the supplemented NOS medium; however, 50 ml of rabbit
serum was added instead of the pectin (6, 20). For the
analyses, the bacteria were centrifuged at 11,000 rpm for 20 min and
washed, and the cells were resuspended in phosphate-buffered saline
(PBS; 0.05 M phosphate, pH 7.2). Bacterial cell counts were estimated
using a hemocytometer. The purity of the culture was determined by
phase-contrast and dark-field microscopic observations.
Formalinized T. pectinovorum was prepared by incubating
washed bacteria with 0.5% buffered formal saline overnight on the rotator (11). The following day, the formalinized bacteria
were washed with PBS, and the pellet was broken apart by forcing the bacteria through gradually smaller gauge needles. T. pectinovorum was then counted and resuspended at the
appropriate dilution in Dulbecco modified Eagle medium (DMEM)
containing 1% fetal bovine serum (FBS).
HGFs.
Three different cultures of normal HGFs (Gin-4, Gin-7,
and Gin-8) (44) were grown to confluency in DMEM
supplemented with 10% FBS (HyClone, Logan, Utah), antibiotics
(penicillin [100/ml] and streptomycin [100/ml]; Gibco, Grand
Island, N.Y.), and L-glutamine (2 mM; Gibco) at 37°C in
5% CO2 and moist air (44). The cells routinely
reached confluency by approximately 4 to 5 days and were passaged by a
1:3 split. All experiments were carried out with gingival fibroblasts
at passages <12.
In vitro bacterium-gingival-fibroblast interactions.
The
gingival fibroblasts were plated into 24-well microtiter plates at
105 cells/well. They were propagated to confluency
(~5 × 105/well) for 2 days prior to
experimentation. The bacteria were resuspended in DMEM and 1% FBS
without antibiotics, and 1 ml was added to the test wells. Three
different concentrations of bacteria were used for the challenge
(5 × 107, 5 × 108, and 5 × 109/ml), and all assessments were made in triplicate.
Supernatants were collected at six different time points (1, 3, 6, 12, 24, and 48 h following challenge), centrifuged (13,000 × g for 5 min), and frozen in multiple aliquots at
80°C.
ELISA for cytokines.
Two different sequential enzyme-linked
immunosorbent assay (ELISA) procedures (43) were performed
to detect 10 different host factors: IL-1
, IL-6, IL-8, TNF-
,
GM-CSF, platelet-derived growth factor (PDGF), MCP-1, IL-1
, IL-10,
and IFN-
. Microtiter plate wells were incubated with 0.2 ml of a
5-µg/ml concentration of mouse monoclonal antibody to each of the
cytokines (except PDGF, which utilized a goat polyclonal antibody) in
carbonate-bicarbonate buffer as a capture antibody. After 3 to 4 h
of incubation at 37°C, the solution was removed and 1% bovine serum
albumin (BSA; Sigma, St. Louis, Mo.) in PBS was added to block unbound
sites in the wells. The plates were stored with the BSA at 4°C at
least overnight. Samples were assayed in the sequence of the least to the most prominent cytokine in the fluid to be analyzed based upon our
previous studies, as well as the minimal detectable dose of the assays.
A pooled recombinant standard of cytokines was used on all the plates.
Each of the cytokines in the pooled standard was adjusted to 1,000 pg/0.2 ml and diluted serially twofold to 1.95 pg/0.2 ml. All samples
were added to the first plate of the sequence (e.g., anti-IL-1
) in
duplicate using 200 µl of the undiluted supernatants per well. The
same volume of the pooled standard was added to the ELISA plate. After
1 h of incubation at 37°C, each sample well and each standard
well was replicate transferred (175 µl) directly from the first plate
and mixed with 25 µl of sample diluent in the same location of the
second plate in the sequence (e.g., anti-GM-CSF-coated plate) and
incubated at 37°C for 1 h. The first plate was then developed
with rabbit antibody (e.g., anti-IL-1
), goat anti-rabbit
immunoglobulin G conjugated to alkaline phosphatase and
p-nitrophenylphosphate as the substrate (43). At
the end of the incubation of the second plate in the sequence (e.g.,
GM-CSF), 175 µl of the samples and standards was replicate
transferred to a third plate. The second plate was developed with
rabbit antibody (e.g., anti-GM-CSF) and additional reagents as
described above. This sequence of events was repeated (e.g., IFN-
,
IL-6, and IL-8) throughout the assay until all plates were incubated
with the appropriate rabbit antisera. The second cytokine series
included IL-10, PDGF, TNF-
, MCP-1, and IL-1
, which were analyzed
using specific capture and developing antibodies as described above.
The commercial sources of the various reagents were as follows
(recombinant standard: monoclonal capture: polyclonal developing
reagent): IL-1

(Sigma: Genzyme [Cambridge, Mass.]: Sigma), IL-1
(R&D [Minneapolis, Minn.]: Biosource [Camarillo, Calif.]: Sigma),
IL-6 (R&D: Biosource: Sigma), IL-8 (Biosource: Biosource: Endogen
[Cambridge, Mass.]), IL-10 (Genzyme: Biosource [i.e., rat]:
Genzyme),
IFN-

(R&D: Biosource: Genzyme), TNF-

(Biosource:
Genzyme: Genzyme),
GM-CSF (R&D: Genzyme: Genzyme), MCP-1 (Sigma: Sigma:
Chemicon
[Temecula, Calif.]), and PDGF (BioDesign [Kennebunk,
Maine]: R&D:
Genzyme).
The levels of cytokines in the samples were determined using Dynatech
Biolinx software (Dynatech, Chantilly, Va.) with a sigmoidal
fit.
Intraplate and interplate variability was accepted with a
sample
duplicate variation of

15%, and the standard curve between
plates
required (i) a maximum optical density of at least 1.0
(no more than
20% variation), (ii) no significant difference (
P > 0.05) in the slopes, and (iii) a background of <0.15.
Statistical analyses.
The results were analyzed using a
two-tailed Student t test (Minitab, State College, Pa.) to
assess the null hypotheses that T. pectinovorum and T. denticola induce HGF secretion of similar proinflammatory
mediators and cytokines, that different HGF cell lines respond
similarly to challenge with oral treponemes, and that live and killed
T. pectinovorum bacteria elicit similar mediators and
cytokines from HGFs.
 |
RESULTS |
Cytokine responses of gingival fibroblasts to oral treponemes.
Basal levels of 10 cytokines and/or growth factors were evaluated in
HGF cell cultures from three periodontally healthy individuals. During
a 48-h in vitro analysis interval, we could detect no production of
IFN-
, TNF-
, PDGF, GM-CSF, IL-1
, IL-10, and IL-1
above the minimum detectable level of the assays. However, the gingival fibroblasts were capable of producing IL-6, IL-8, and MCP-1 without exogenous challenge. These levels were ca. 200 to 500 pg/ml (IL-6), ca.
110 to 175 pg/ml (IL-8), and ca. 150 to 500 pg/ml (MCP-1) (Fig.
1). Generally, the maximum levels of
these cytokines were noted at 12 to 24 h (IL-6 and MCP-1) and 6 to
12 h (IL-8) during the culture period.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 1.
Basal cytokine production by the gingival fibroblast
populations. Ten different cytokines were tested and only IL-6, IL-8,
and MCP-1 were detected in unstimulated cultures. The points denote the
mean production levels from triplicate determinations with each cell
line. The stippled areas denote the minimum detectable dose for each of
the assays. The 48-h data are not presented since the cytokine levels
generally dropped, probably due to degradation, and alterations were
noted microscopically in the structural integrity of the fibroblasts.
|
|
The gingival fibroblasts were then challenged with viable
T. denticola and
T. pectinovorum. Each of the two
T. pectinovorum and three
T. denticola strains stimulated
the individual fibroblast
cell lines to produce elevated levels of IL-6
(Fig.
2), with an
eightfold increase (ca.
2,000 to 6,000 pg/ml), although the clinical
S1 isolate of
T. pectinovorum was uniformly more stimulatory.
Examination of IL-8
levels demonstrated a substantial variation
among the strains within
each species, although at least one isolate
stimulated IL-8 levels by
20- to 50-fold (Fig.
2). Again, the
T. pectinovorum clinical
isolate, S1, exhibited significantly
greater induction compared to all
of the other strains. Both of
the
T. pectinovorum strains
stimulated MCP-1 by 7- to 10-fold
(Fig.
2), while MCP-1 levels were
negligible after
T. denticola challenge and were
significantly lower than even basal levels
produced by the gingival
fibroblasts. After challenge of all three
gingival fibroblast lines
with various concentrations of these
oral treponemes, no induction of
IL-1

, IL-1

, TNF-

, GM-SCF,
IFN-

, PDGF, or IL-10 could be
detected.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 2.
IL-6, IL-8, and MCP-1 production by three different cell
lines (Gin-4, Gin-7, and Gin-8) after challenge with live T. denticola or T. pectinovorum strains. The cells were
stimulated with 5 × 109 bacteria. The bars denote the
mean level of cytokine detected during a 24-h culture period from
triplicate determinations of each cell line, and the vertical line
denotes 1 standard deviation.
|
|
Characteristics of IL-6, IL-8, and MCP-1 induction for individual
gingival fibroblast cell lines.
Three different normal gingival
fibroblast cell lines were used during this study: Gin-4, Gin-7, and
Gin-8. In general, a dose response for each of the three cytokines was
noted when the gingival fibroblast cell cultures were stimulated by
T. pectinovorum strain S1 (Fig.
3). A significantly elevated IL-6 level
was detected from 6 to 24 h (P < 0.003 to
P < 0.05) versus basal levels, with the various
challenge conditions, with peak levels of IL-6 noted at 6 to 12 h
postchallenge. T. pectinovorum induced similar levels of
IL-8 production by the gingival fibroblast cells (Fig. 3). The highest
dose elicited peak levels by 6 to 12 h (P < 0.006 to P < 0.03 versus basal levels), while the levels at
the lowest dose peaked at 24 h (P < 0.0001 to
P < 0.05 versus basal levels). MCP-1 was
produced following stimulation of all three gingival fibroblast
cultures by each of the doses of T. pectinovorum (Fig. 3).
The levels were observed by as early as 6 h and routinely peaked
at 6 to 12 h. Interestingly, the Gin-8 gingival fibroblast cell
population appeared to be routinely less responsive to challenge with
the T. pectinovorum strain. We did observe a substantial difference in the basal production of the fibroblast cell lines of
MCP-1 (e.g., compare Fig. 1 with Fig. 3). We have noted previously that
the gingival fibroblast responses are related to the concentration and
the qualities of the FBS used in these type of in vitro studies (11). Thus, we propose that the variances in basal
production across experiments are related to the FBS; nevertheless, the
stimulated responses appeared to be proportional irrespective of the
absolute basal level.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 3.
IL-6, IL-8, and MCP-1 basal production (B) or production
following challenge of individual gingival fibroblast populations of
Gin-4, Gin-7, and Gin-8 with 5 × 107 ( ), 5 × 108 ( ), or 5 × 109 ( ) T. pectinovorum strain S1 bacteria. The points denote the mean levels
from triplicate determinations at each time point. The variation of the
replicate measures was consistently <12% of the mean.
|
|
T. denticola 35404 stimulated peak levels of IL-6
(
P < 0.019 to
P < 0.049) by 24 h
after challenge (Fig.
4). As observed
with
IL-6, IL-8 production reached peak levels by 24 h in a
dose-response
fashion with all gingival fibroblast cell cultures (Fig.
4). Importantly,
both IL-6 and IL-8 levels were significantly lower
when comparing
the
T. denticola challenge to the
T. pectinovorum challenge. MCP-1
levels were routinely decreased
below basal gingival fibroblast
production following challenge with
T. denticola (Fig.
4). An
inverse relationship of MCP-1
level in the gingival fibroblast
cultures to
T. denticola
dose was observed. As was noted with
the
T. pectinovorum
challenge, the Gin-8 gingival fibroblast population
was significantly
less responsive with each cytokine to this
T. denticola
stimulation. Interestingly, the highest dose of
T. denticola used for challenge was routinely accompanied by a decreased level
of
cytokines.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 4.
IL-6, IL-8, and MCP-1 basal production (B) or production
following challenge of individual gingival fibroblast populations of
Gin-4, Gin-7, and Gin-8 with 5 × 107 ( ), 5 × 108 ( ), or 5 × 109 ( ) T. denticola strain 33504 bacteria. The points denote the mean levels
from triplicate determinations at each time point. The variation of the
replicate measures was consistently <15% of the mean.
|
|
Characteristics of cytokine production by gingival fibroblasts
following challenge with live versus dead T. pectinovorum.
Substantial data has been gathered suggesting that during the
progression of periodontitis, large numbers of intact (e.g., viable)
bacteria are not routinely detected in the damaged tissue or at the
progressing front of the disease (36, 37). Thus, to evaluate
whether live treponemes are required to stimulate the gingival
fibroblast cell responses, we compared gingival fibroblast reactions to
live and dead T. pectinovorum. We targeted IL-6 and IL-8 to
discriminate differences in host-bacterium interactions. The results
indicate that dead T. pectinovorum induced levels of both
cytokines which were approximately twofold greater than those noted
with the live microorganisms (Fig. 5).

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 5.
IL-6 and IL-8 production after challenge of Gin-4 or
Gin-7 gingival fibroblast populations with 5 × 108
and 5 × 109 live or dead T. pectinovorum
S1 bacteria. The bars denote the mean levels from triplicate
determinations at the peak time for each cytokine (e.g., 12 h for
treatment with the live bacteria and 48 h for treatment with dead
bacteria). The vertical bracket encloses 1 standard deviation. N/A,
data not available.
|
|
 |
DISCUSSION |
Gingival fibroblasts are the cells comprising the connective
tissue surrounding the teeth. Gingival tissues can be removed and, in
culture, these fibroblasts proliferate for many generations in vitro.
These resident cells of the oral cavity have surface receptors that are
used for communication, and it is becoming increasingly apparent that
the resident cells of the periodontium play an important role in
cytokine production in the local environment. The quality and quantity
of these receptors can change in response to the external environment
(2, 12, 17, 22, 23, 29). The receptors are generally
specific for various macromolecules and, when they are complexed,
signals are transduced within the cell. This receptor triggering
initiates a series of events in response to the binding process.
Certain of these events inside the cell result in the production of
cytokines (4). Epithelial cells (3, 8, 39) and
fibroblasts (3, 8, 11, 39, 53) can both produce these
macromolecules for cell communication and to amplify the immune system
to control infections. However, there are minimal data on the
interactions of oral spirochetes with these resident cells. The present
studies were performed to specifically evaluate the outcome of T. denticola and T. pectinovorum interaction with HGFs. In
particular, we emphasized cytokine production as a measure of this
interaction. This study shows that neither T. pectinovorum
nor T. denticola stimulated IL-1
, IL-1
, IL-10, PDGF,
GM-CSF, IFN-
, or TNF-
production by the gingival fibroblasts. The
results suggest that (i) the spirochetes do not interact with appropriate receptors on the fibroblasts which are required for triggering synthesis of these cytokines, (ii) gingival fibroblasts are
incapable of producing these cytokines, (iii) these cytokines are
rapidly degraded or removed by binding to the bacteria or host cells,
and/or (iv) the levels produced by the gingival fibroblasts are too low
to be detected by the systems utilized here. While our studies do not
provide direct proof to select among these options, other studies have
identified the capacity of gingival fibroblasts to produce certain of
the cytokines (1, 44). While T. denticola
exhibits some proteolytic activity, which may contribute to degradation
of cytokines, we feel it most likely that these treponemes do not
trigger the appropriate surface receptors on the gingival fibroblasts
required for an appropriate signal transduction leading to specific
cytokine synthesis.
Three cytokines, IL-6, IL-8, and MCP-1, were produced by gingival
fibroblasts, both constitutively and in significantly increased levels
after challenge with T. denticola and/or T. pectinovorum. Three normal gingival fibroblast cell lines,
derived from unrelated healthy donors, were stimulated with the
treponemes, and with each gingival fibroblast population T. pectinovorum elicited IL-6 levels which were 4- to 10-fold greater
than those induced by T. denticola. Interestingly, the
largest amount of T. denticola (109) used to
challenge the gingival fibroblasts appeared to consistently be
associated with lower levels of IL-6 than did smaller T. denticola challenge doses. We have noted previously that IL-6 is
particularly susceptible to proteolytic degradation by the trypsin-like
enzyme activities of Porphyromonas gingivalis
(44). Since T. denticola strains also produce a
trypsin-like activity (18), the IL-6 could be
proteolytically destroyed at larger amounts of bacterial challenge. In
contrast, the T. pectinovorum strains lack this activity. As
with IL-6, IL-8 production was three- to fourfold greater with T. pectinovorum than with T. denticola stimulation of the
gingival fibroblasts. Additionally, similar to IL-6, larger doses of
T. denticola either stimulated less IL-8, accelerated degradation of this chemokine, or bound the molecules to the bacterial surface and eliminated them from the extracellular milieu.
A major difference in the cytokine profiles induced by the two
treponemes was the substantial production of MCP-1 induced by T. pectinovorum. In contrast, T. denticola appeared to
inhibit basal production of MCP-1 by the gingival fibroblasts, such
that by the 48-h time point, the stimulated cultures showed <80 pg/ml, while basal levels of 150 to 500 pg/ml were produced by the
unchallenged gingival fibroblasts. These results are consistent with
T. pectinovorum potentially interacting via multiple binding
sites on the gingival fibroblasts or specifically targeting unique
receptors, leading to the production of greater levels and unique
cytokines. Importantly, the production of MCP-1, which attracts
macrophages to the site of inflammation or infection and can activate
these cells (14, 34), implies that both the innate and
adaptive immune systems could contribute to the local response to this
microorganism. In contrast, T. denticola has developed a
strategy to impede this activity of the host response. Additionally, we
have principally isolated T. pectinovorum from the
subgingival plaque of human immunodeficiency virus (HIV)-infected
patients with periodontitis, whereas T. denticola
predominates in seronegative periodontitis patients (48).
Since macrophages have been identified as a long-lived source of HIV
production in humans (7, 10), particularly following
activation of the cells (27, 28, 51), the ability of
T. pectinovorum to elicit MCP-1 in the local gingival
environment could have important ramifications associated with viral
activation and production within the periodontal environment. Thus, the
association of necrotizing ulcerative periodontitis in HIV-infected
patients with a rapid decrease in survival time could reflect this
immune stimulation by members of the oral microbiota in this pathogenic ecology.
Three normal gingival fibroblast cell lines from different subjects
were tested (Gin-4, Gin-7, and Gin-8). The results indicated variations
in responsiveness to bacterial challenge. IL-6 production demonstrated
a profile of Gin-4
Gin-7 > Gin-8 levels when either treponeme was used. Moreover, T. pectinovorum stimulated 4- to 10-fold-greater levels of IL-6 in each cell culture compared to T. denticola. IL-8 production demonstrated a profile of
Gin-4 = Gin-7 > Gin-8 responses to both treponemes. As noted
with IL-6, Gin-4 and Gin-7 produced approximately 10-fold more IL-8
after T. pectinovorum challenge. In contrast, Gin-8 was
generally unresponsive to T. denticola for production
of this chemokine. Gin-4 and Gin-7 produced at least twofold more MCP-1
than Gin-8 after T. pectinovorum challenge, while none
of the cell lines consistently responded to T. denticola in
producing this cytokine. We conclude that gingival fibroblast cell
populations derived from different normal subjects react differently to
these bacterial challenges and suggest the potential for host
variability in responsiveness. Currently, few genetic studies on
periodontitis have been performed, although promising evidence suggests
some genetic linkage (15, 24, 47), including host response
alterations associated with genetic polymorphisms (19, 31,
45). These published studies suggested a genetic contribution to
the characteristics of the inflammatory and immune response to oral
bacterial challenge and the subsequent expression of periodontal
disease. Thus, the local environmental factors (e.g., bacteria) not
only impact the immune system but also may alter resident cell (e.g.,
gingival fibroblast) functions. Our findings suggest variation in
gingival fibroblast responsiveness to proposed periodontal pathogens
that may be an additional consideration in risk assessment. Studies by
Hassell and Harris (15) have also supported population
differences in the proliferative capacities of gingival fibroblasts.
Whether genetic influences truly impact upon fibroblast functions and
responsiveness, as evaluated here, requires additional exploration.
We subsequently determined differences between cytokine induction by
live and dead T. pectinovorum. The results showed that dead
bacteria stimulated a greater production of both IL-6 and IL-8 than did
live bacteria. Specifically, the live and dead bacteria induced
cytokine production, which increased through 12 to 24 h. With live
T. pectinovorum, the levels then decreased significantly, while the dead bacteria continued to induce the production of cytokines
through 48 h, which was the termination point of these cultures.
Furthermore, with live microorganisms, by 48 h the gingival fibroblasts generally exhibited altered cellular structure, suggesting likely deleterious actions on the functions of these cells. The differences could be due to (i) the degradation of the cytokines by
fibroblast enzymatic activity, (ii) the degradation of IL-6 and IL-8 by
the bacteria, or (iii) the cytokines binding to the bacteria or to
increased numbers of receptors on the gingival fibroblasts stimulated
by the live microorganisms. Alternatively, the treated spirochetes may
exhibit a more rigid structure, thus cross-linking more gingival
fibroblast receptors stimulating cytokine production. Additional
studies are required to differentiate between these mechanisms and to
evaluate the biological significance of this finding. Irrespective of
the mechanism, the results suggest that nonviable bacteria or their
products can effectively stimulate cytokine production by gingival fibroblasts.
 |
ACKNOWLEDGMENTS |
This work was supported by U.S. Public Health Service grant
DE-11368 from the National Institute of Dental and Craniofacial Research.
We thank S. Walker and L. Kesavalu for technical assistance in
preparation of the live and formalin-killed treponemes. We also express
our appreciation for contributions by Stanley Holt in the development
of the experimental designs.
 |
FOOTNOTES |
*
Corresponding author. Present address: Center for Oral
Health Research, College of Dentistry, DS44, University of Kentucky, Lexington, KY 40536-0297. Phone: (859) 323-8229. Fax: (859) 257-6566. E-mail: jleber2{at}popuky.edu.
Editor:
J. D. Clements
 |
REFERENCES |
| 1.
|
Agarwal, S.,
C. Baran,
N. P. Piesco,
J. C. Quintero,
H. H. Langkamp,
L. P. Johns, and C. S. Chandra.
1995.
Synthesis of proinflammatory cytokines by human gingival fibroblasts in response to lipopolysaccharides and interleukin-1 .
J. Periodontal Res.
30:382-389[CrossRef][Medline].
|
| 2.
|
Bastian, S.,
J. L. Paquet,
C. Robert,
B. Cremers,
B. Loillier,
J. F. Larrivee,
D. R. Bachvarov,
F. Marceau, and D. Pruneau.
1998.
Interleukin 8 (IL-8) induces the expression of kinin B1 receptor in human lung fibroblasts.
Biochem. Biophys. Res. Commun.
253:750-755[CrossRef][Medline].
|
| 3.
|
Birkedal-Hansen, H.
1993.
Role of cytokines and inflammatory mediators in tissue destruction.
J. Periodontal Res.
28:500-510[CrossRef][Medline].
|
| 4.
|
Bliska, J. B.,
J. E. Galan, and S. Falkow.
1993.
Signal transduction in the mammalian cell during bacterial attachment and entry.
Cell
73:903-920[CrossRef][Medline].
|
| 5.
|
Brennan, F. M.
1999.
Interleukin 10 and arthritis.
Rheumatology
38:293-297[Free Full Text].
|
| 6.
|
Chan, E. C. S.,
R. Siboo,
L. Z. G. Touyz,
Y.-S. Qiu, and A. Klitorinos.
1993.
A successful method for quantifying viable oral anaerobic spirochetes.
Oral Microbiol. Immunol.
8:80-83[Medline].
|
| 7.
|
Collman, R.G., and Y. Yi.
1999.
Cofactors for human immunodeficiency virus entry into primary macrophages.
J. Infect. Dis.
179(Suppl. 3):S422-S426.
|
| 8.
|
Curfs, J. H.,
J. F. Meis, and J. A. Hoogkamp-Korstanje.
1997.
A primer on cytokines: sources, receptors, effects, and inducers.
Clin. Microbiol. Rev.
10:742-780[Abstract].
|
| 9.
|
Darveau, R. P.,
A. Tanner, and R. C. Page.
1997.
The microbial challenge in periodontitis.
Periodontol. 2000
14:12-32[Medline].
|
| 10.
|
Dimitrov, D. S.,
D. Norwood,
T. S. Stantchev,
Y. Feng,
X. Xiao, and C. C. Broder.
1999.
A mechanism of resistance to HIV-1 entry: inefficient interactions of CXCR4 with CD4 and gp120 in macrophages.
Virology
259:1-6[CrossRef][Medline].
|
| 11.
|
Dongari-Bagtzoglou, A., and J. L. Ebersole.
1996.
Production of inflammatory mediators and cytokines by human gingival fibroblasts following bacterial challenge.
J. Periodontal Res.
31:90-98[CrossRef][Medline].
|
| 12.
|
Ebersole, J. L.
1996.
Immune responses in periodontal diseases, p. 109-158.
In
T. G. Wilson, and K. S. Kornman (ed.), Fundamentals of periodontics. Quintessence Publishing Co., Inc., Chicago, Ill.
|
| 13.
|
Ferreira, M. B., and A. G. Carlos.
1998.
Cytokines and asthma.
J. Investig. Allerg. Clin. Immunol.
8:141-148[Medline].
|
| 14.
|
Graves, D. T., and Y. Jiang.
1995.
Chemokines, a family of chemotactic cytokines.
Crit. Rev. Oral Biol. Med.
6:109-118[Abstract/Free Full Text].
|
| 15.
|
Hassell, T. M., and E. L. Harris.
1995.
Genetic influences in caries and periodontal diseases.
Crit. Rev. Oral Biol. Med.
6:319-342[Abstract/Free Full Text].
|
| 16.
|
Heasman, P. A.,
J. G. Collins, and S. Offenbacher.
1993.
Changes in crevicular fluid levels of interleukin-1 , leukotriene B4, prostaglandin E2, thromboxane B2 and tumor necrosis factor in experimental gingivitis in humans.
J. Periodontal Res.
28:241-247[CrossRef][Medline].
|
| 17.
|
Hou, L.,
S. Ravenall,
M. G. Macey,
P. Harriott,
S. Kapas, and G. L. Howells.
1998.
Protease-activated receptors and their role in IL-6 and NF-IL-6 expression in human gingival fibroblasts.
J. Periodontal Res.
33:205-211[CrossRef][Medline].
|
| 18.
|
Kesavalu, L.,
S. G. Walker,
S. C. Holt,
R. R. Crawley, and J. L. Ebersole.
1997.
Virulence characteristics of oral treponemes in a murine model.
Infect. Immun.
65:5096-5102[Abstract].
|
| 19.
|
Kornman, K. S.,
A. Crane,
H.-Y. Wang,
F. S. di Giovine,
M. G. Newman,
F. W. Pirk,
T. G. Wilson, Jr.,
F. L. Higgenbottom, and G. W. Duff.
1997.
The interleukin-1 genotype as a severity factor in adult periodontal disease.
J. Clin. Periodontol.
24:72-77[CrossRef][Medline].
|
| 20.
|
Leschine, S. B., and E. Canale-Parola.
1980.
Rifampin as a selective agent for isolation of oral spirochetes.
J. Clin. Microbiol.
6:792-795.
|
| 21.
|
Loesche, W. J.
1988.
The role of spirochetes in periodontal disease.
Adv. Dent. Res.
2:275-283[Abstract/Free Full Text].
|
| 22.
|
Lurton, J.,
H. Soto,
A. S. Narayanan, and G. Raghu.
1999.
Regulation of human lung fibroblast C1q-receptors by transforming growth factor-beta and tumor necrosis factor-alpha.
Exp. Lung Res.
25:151-164[CrossRef][Medline].
|
| 23.
|
Malmstrom, J., and G. Westergren-Thorsson.
1998.
Heparan-sulfate upregulates platelet-derived growth factor receptors on human lung fibroblasts.
Glycobiology
8:1149-1155[Abstract/Free Full Text].
|
| 24.
|
Marazita, M. L.,
J. A. Burmeister,
J. C. Gunsolley,
T. E. Koertge,
K. Lake, and H. A. Schenkein.
1994.
Evidence for autosomal dominant inheritance and race-specific heterogeneity in early-onset periodontitis.
J. Periodontol.
65:623-630[Medline].
|
| 25.
|
Masada, M. P.,
R. Persson,
J. S. Kenney,
S. W. Lee,
R. C. Page, and A. C. Allison.
1990.
Measurement of interleukin-1 and -1 in gingival crevicular fluid: implications for the pathogenesis of periodontal disease.
J. Periodontal Res.
25:156-163[CrossRef][Medline].
|
| 26.
|
Moore, W. E. C., and L. V. H. Moore.
1994.
The bacteria of periodontal diseases.
Periodontol. 2000
5:66-77[Medline].
|
| 27.
|
Moriuchi, H.,
M. Moriuchi, and A. S. Fauci.
1999.
Induction of HIV-1 replication by allogeneic stimulation.
J. Immunol.
162:7543-7548[Abstract/Free Full Text].
|
| 28.
|
Moriuchi, M.,
H. Moriuchi,
W. Turner, and A. S. Fauci.
1998.
Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1.
J. Clin. Investig.
102:1540-1550[Medline].
|
| 29.
|
Ogura, N.,
H. Nagura, and Y. Abiko.
1999.
Increase of urokinase-type plasminogen activator receptor expression in human gingival fibroblasts by Porphyromonas gingivalis lipopolysaccharide.
J. Periodontol.
70:402-408[CrossRef][Medline].
|
| 30.
|
Page, R. C.
1991.
The role of inflammatory mediators in the pathogenesis of periodontal disease.
J. Periodontal Res.
26:230-242[CrossRef][Medline].
|
| 31.
|
Pociot, F.,
J. Molvig,
L. Wogensen,
H. Worsaae, and J. Nerup.
1992.
A Taq I polymorphism in the human interleukin-1 (IL-1 ) gene correlates with IL-1 secretion in vitro.
Eur. J. Clin. Investig.
22:224-231.
|
| 32.
|
Reinhardt, R. A.,
M. P. Masada,
W. B. Daldahl,
L. M. DuBois,
K. S. Kornman,
J.-L. Choi,
K. L. Kalkwarf, and A. C. Allison.
1993.
Gingival fluid IL-1 and IL-6 levels in refractory periodontitis.
J. Clin. Periodontol.
20:225-231[CrossRef][Medline].
|
| 33.
|
Roberts, F. A.,
R. D. Hockett, Jr.,
R. P. Bucy, and S. M. Michalek.
1997.
Quantitative assessment of inflammatory cytokine gene expression in chronic adult periodontitis.
Oral Microbiol. Immunol.
12:336-344[Medline].
|
| 34.
|
Rollins, B. J.
1996.
Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease.
Mol. Med. Today
2:198-204[CrossRef][Medline].
|
| 35.
|
Rossomando, E. F., and L. White.
1993.
A novel method for the detection of TNF-alpha in gingival crevicular fluid.
J. Periodontol.
64:445-449[Medline].
|
| 36.
|
Saglie, F. R.
1991.
Bacterial invasion and its role in the pathogenesis of periodontal disease, p. 27-40.
In
S. Hamada, S. C. Holt, and J. R. McGhee (ed.), Periodontal disease: pathogens and host responses. Quintessence Publishing Co., Ltd., Tokyo, Japan.
|
| 37.
|
Sandros, J.,
P. N. Papapanou,
U. Nannmark, and G. Dahlén.
1994.
Porphyromonas gingivalis invades human pocket epithelium in vitro.
J. Periodontal Res.
29:62-69[CrossRef][Medline].
|
| 38.
|
Schwartz, Z.,
D. D. Dean, and B. D. Boyan.
1996.
The biochemistry and physiology of the periodontium, p. 61-107.
In
T. G. Wilson, and K. S. Kornman (ed.), Fundamentals of periodontics. Quintessence Publishing Co., Inc., Chicago, Ill.
|
| 39.
| Shupp, E., M. J. Steffen, and J. L. Ebersole. Cytokines produced by epithelial cells and fibroblasts
stimulated with Treponema pectinovorum. J. Dent. Res., in
press.
|
| 40.
|
Simonson, L. G.,
C. H. Goodman, and H. E. Morton.
1990.
Quantitative immunoassay of Treponema denticola serovar in adult periodontitis.
J. Clin. Microbiol.
28:1493-1496[Abstract/Free Full Text].
|
| 41.
|
Smibert, R. M.,
J. L. Johnson, and R. R. Ranney.
1984.
Treponema socranskii sp. nov., Treponema socranskii subsp. socranskii subsp. nov., Treponema socranskii subsp. buccale subsp. nov., and Treponema socranskii subsp. paredis subsp. nov. isolated from humans with experimental gingivitis and periodontitis.
Int. J. Syst. Bacteriol.
34:456-462.
|
| 42.
|
Socransky, S. S.,
A. D. Haffajee,
L. A. Ximenez-Fyvie,
M. Feres, and D. Mager.
1999.
Ecological considerations in the treatment of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis periodontal infections.
Periodontol. 2000
20:341-362[Medline].
|
| 43.
|
Steffen, M. J., and J. L. Ebersole.
1996.
Sequential ELISA for cytokine levels in limited volumes of biological fluids.
BioTechniques
21:504-509[Medline].
|
| 44.
| Steffen, M., S. C. Holt, and J. L. Ebersole. Porphyromonas gingivalis induction of
mediator and cytokine secretion by human gingival fibroblasts. Oral
Microbiol. Immunol., in press.
|
| 45.
|
Tangada, S. D.,
J. V. Califano,
K. Nakashima,
S. M. Quinn,
J. B. Zhang,
J. C. Gunsolley,
H. A. Schenkein, and J. G. Tew.
1997.
The effect of smoking on serum IgG2 reactive with Actinobacillus actinomycetemcomitans in early-onset periodontitis patients.
J. Periodontol.
68:842-850[Medline].
|
| 46.
|
Tonetti, M. S.,
K. Freiburghaus,
N. P. Lang, and M. Bickel.
1993.
Detection of interleukin-8 and matrix metalloproteinases transcripts in healthy and diseased gingival biopsies by RNA/PCR.
J. Periodontal Res.
28:511-513[CrossRef][Medline].
|
| 47.
|
Van Dyke, T. E.,
M. A. Lester, and L. Shapira.
1993.
The role of the host response in periodontal disease progression: implications for future treatment strategies.
J. Periodontol.
64:792-806[Medline].
|
| 48.
|
Walker, S. G.,
J. L. Ebersole, and S. C. Holt.
1997.
Identification, isolation, and characterization of the 42-kilodalton major outer membrane protein (MompA) from Treponema pectinovorum ATCC 33768.
J. Bacteriol.
179:6441-6447[Abstract/Free Full Text].
|
| 49.
|
Walker, S. G.,
J. L. Ebersole, and S. C. Holt.
1999.
Studies on the binding of Treponema pectinovorum to HEp-2 epithelial cells.
Oral Microbiol. Immunol.
14:165-171[CrossRef][Medline].
|
| 50.
|
Weinberg, A., and S. C. Holt.
1990.
Interaction of Treponema denticola TD-4, GM-1, and MS25 with human gingival fibroblasts.
Infect. Immun.
58:1720-1729[Abstract/Free Full Text].
|
| 51.
|
Wodarz, D.,
A. L. Lloyd,
V. A. Jansen, and M. A. Nowak.
1999.
Dynamics of macrophage and T cell infection by HIV.
J. Theor. Biol.
196:101-113[CrossRef][Medline].
|
| 52.
|
Yamazaki, K.,
T. Nakajima,
Y. Kubota,
E. Gemmell,
G. Seymour, and K. Hara.
1997.
Cytokine messenger RNA expression in chronic inflammatory periodontal disease.
Oral Microbiol. Immunol.
12:281-287[Medline].
|
| 53.
|
Yu, X., and D. Graves.
1995.
Fibroblasts, mononuclear phagocytes, and endothelial cells express monocyte chemoattractant protein-1 (MCP-1) in inflamed human gingiva.
J. Periodontol.
66:80-88[Medline].
|
Infection and Immunity, September 2000, p. 5284-5292, Vol. 68, No. 9
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
O'Brien-Simpson, N. M., Pathirana, R. D., Walker, G. D., Reynolds, E. C.
(2009). Porphyromonas gingivalis RgpA-Kgp Proteinase-Adhesin Complexes Penetrate Gingival Tissue and Induce Proinflammatory Cytokines or Apoptosis in a Concentration-Dependent Manner. Infect. Immun.
77: 1246-1261
[Abstract]
[Full Text]
-
Lee, S. F., Andrian, E., Rowland, E., Marquez, I. C.
(2009). Immune Response and Alveolar Bone Resorption in a Mouse Model of Treponema denticola Infection. Infect. Immun.
77: 694-698
[Abstract]
[Full Text]
-
Ruby, J., Rehani, K., Martin, M.
(2007). Treponema denticola Activates Mitogen-Activated Protein Kinase Signal Pathways through Toll-Like Receptor 2. Infect. Immun.
75: 5763-5768
[Abstract]
[Full Text]
-
Miyamoto, M., Ishihara, K., Okuda, K.
(2006). The Treponema denticola Surface Protease Dentilisin Degrades Interleukin-1{beta} (IL-1{beta}), IL-6, and Tumor Necrosis Factor Alpha. Infect. Immun.
74: 2462-2467
[Abstract]
[Full Text]
-
Lee, S.-H., Kim, K.-K., Choi, B.-K.
(2005). Upregulation of Intercellular Adhesion Molecule 1 and Proinflammatory Cytokines by the Major Surface Proteins of Treponema maltophilum and Treponema lecithinolyticum, the Phylogenetic Group IV Oral Spirochetes Associated with Periodontitis and Endodontic Infections. Infect. Immun.
73: 268-276
[Abstract]
[Full Text]
-
Asai, Y., Jinno, T., Ogawa, T.
(2003). Oral Treponemes and Their Outer Membrane Extracts Activate Human Gingival Epithelial Cells through Toll-Like Receptor 2. Infect. Immun.
71: 717-725
[Abstract]
[Full Text]
-
Asai, Y., Jinno, T., Igarashi, H., Ohyama, Y., Ogawa, T.
(2002). Detection and Quantification of Oral Treponemes in Subgingival Plaque by Real-Time PCR. J. Clin. Microbiol.
40: 3334-3340
[Abstract]
[Full Text]
-
Kesavalu, L., Falk, C. W., Davis, K. J., Steffen, M. J., Xu, X., Holt, S. C., Ebersole, J. L.
(2002). Biological Characterization of Lipopolysaccharide from Treponema pectinovorum. Infect. Immun.
70: 211-217
[Abstract]
[Full Text]